课题基金 / 基金详情

项目摘要

项目成果

HARALD PAGANETTI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project we will explore highly innovative planning and delivery strategies to optimally utilize the powerful dose shaping capabilities of IMPT. The theoretical advantage of proton therapy compared to photon therapy is due to the reduced integral dose ("dose bath") and the finite range. The added potential of IMPT compared to IMRT derives from the additional degree of freedom, i.e. the beamlet energy. However, to realize the true potential of IMPT, considerable further research is needed. The specific aims of this project focus on different aspects that influence the power of IMPT: Robust optimization of the dose distributions to reduce their sensitivity to uncertainties, biological dose optimization, personalized treatment optimization, and finally, hypofractionation facilitated via the reduced dose bath achievable with IMPT. This project supports the mission of the NCI to improve the treatment and continuing care of cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy.
  • 批准号:
    10270305
  • 项目类别:
  • 资助金额:
    $65.84万
  • 财政年份:
    2021
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy.
  • 批准号:
    10491847
  • 项目类别:
  • 资助金额:
    $56.33万
  • 财政年份:
    2021
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
Fast Individualized Delivery Adaptation in Proton Therapy
  • 批准号:
    10379929
  • 项目类别:
  • 资助金额:
    $29.81万
  • 财政年份:
    2019
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
Fast Individualized Delivery Adaptation in Proton Therapy
  • 批准号:
    10595078
  • 项目类别:
  • 资助金额:
    $30.04万
  • 财政年份:
    2019
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
海外基金